top of page
post-aspot-bg.jpg

BrainsWay’s TMS Device Cleared for OCD Treatment


The Food and Drug Administration has recently cleared Deep TMS treatment to treat those suffering from Obsession Compulsive Disorder (OCD), as an adjunct therapy to medication and psychotherapy. BrainsWay is now the first and only TMS company in the industry who’s received clearance to treat OCD.


Comments


bottom of page